600mg Daily TRK/ROS1/ALK Inhibitor, $200 Bottle

This thing called entrectinib? It’s like a superhero for certain types of tumors, especially those linked to TRK, ROS1, or ALK, and it’s super useful in dealing with NSCLC, the lung cancer stuff. It’s a multitarget kind of deal, like a Swiss Army knife for kinase inhibitors that hits on specific receptors. You can get it in 100 mg and 200 mg capsule sizes.

They usually say you should take 600 mg a day, once in the morning. It doesn’t matter if you have it with or without food. Each bottle is packed with 30 capsules.

This med is made for people who have these TRK, ROS1, or ALK gene mutations that make tumors grow wild. And the clinical trials say it works pretty well by keeping those kinase kinjas in check, so it can either slow down tumor growth or make ’em smaller in some cases. But hey, everyone’s different, so the right dose is something your healthcare provider will figure out.